Cytokine functions of TIMP-1

C Ries - Cellular and molecular life sciences, 2014 - Springer
The tissue inhibitors of metalloproteinases (TIMPs) are well recognized for their role in
extracellular matrix remodeling by controlling the activity of matrix metalloproteinases …

Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression

Y Gong, UD Chippada-Venkata, WK Oh - Cancers, 2014 - mdpi.com
Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in
the degradation of the extracellular matrix, play an important role in tissue remodeling …

TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression

Y Gong, E Scott, R Lu, Y Xu, WK Oh, Q Yu - PLoS One, 2013 - journals.plos.org
Treatment options for late stage prostate and colon cancer are limited and there is an urgent
need to develop more effective and targeted novel therapies, which starts with identification …

Exosomes are the driving force in preparing the soil for the metastatic seeds: lessons from the prostate cancer

SH Saber, HEA Ali, R Gaballa, M Gaballah, HI Ali… - Cells, 2020 - mdpi.com
Exosomes are nano-membrane vesicles that various cell types secrete during physiological
and pathophysiological conditions. By shuttling bioactive molecules such as nucleic acids …

Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer

G Cheng, X Fan, M Hao, J Wang, X Zhou, X Sun - Molecular cancer, 2016 - Springer
Background Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a multifunctional protein
that can directly regulate apoptosis and metastasis. In this study, we investigated the …

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

RW Ross, MD Galsky, HI Scher, J Magidson… - The lancet …, 2012 - thelancet.com
Background Survival for patients with castration-resistant prostate cancer is highly variable.
We assessed the effectiveness of a whole-blood RNA transcript-based model as a …

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

L Agnello, A d'Argenio, A Caliendo, R Nilo, A Zannetti… - Cells, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is among the most aggressive breast cancer subtypes.
Despite being initially responsive to chemotherapy, patients develop drug-resistant and …

Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis

D Li, H Lv, X Hao, B Hu, Y Song - Cancer management and …, 2018 - Taylor & Francis
Background Many studies have evaluated the relationship between alkaline phosphatase
(ALP) and the prognosis for prostate cancer (PCa). But they have not reached a widespread …

Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal …

NM Byrne, H Nesbitt, L Ming, SR McKeown… - British journal of …, 2016 - nature.com
Background: When single-agent androgen deprivation therapy (ADT) is administered for
locally advanced prostate cancer, men usually relapse within 1–2 years with more malignant …

Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer

T Ando, D Charindra, M Shrestha, H Umehara, I Ogawa… - Oncogene, 2018 - nature.com
Tissue inhibitor of metalloproteinase-1 (TIMP-1), a member of the TIMP family (TIMP-1 to 4),
is highly expressed in various types of cancer and forms a complex with its receptor CD63 …